Olink at the NUS Medicine Protein Biomarker Discovery Core Facility opening ceremony & scientific symposium

On Monday, 6th March, the Opening Ceremony of the NUS Medicine Protein Biomarker Discovery Core Facility and accompanying scientific symposium, “Biomarkers and Multi-omics Shape Precision Medicine” were held at the NUS Yong Loo Lin School of Medicine in Singapore. The focus of the scientific symposium was around how to better support precision medicine and population health studies, and the invited speakers’ talks were inspiring and thought-provoking in this regard.

Symposium presentations:

  • Transforming health in Singapore through Precision Medicine: Prof. Patrick Tan, Executive Director, PRECISE (Precision Health Research, Singapore) and A*STAR Professor, Duke-NUS Medical School.
  • The UK Biobank story: Prof. Naomi Allen, Chief Scientist UK Biobank.
  • Measuring Aging With Biomarkers: Prof. Brian Kennedy, Distinguished Professor of Biochemistry and Physiology, NUS Yong Loo Lin School of Medicine.
  • Unleashing Discovery of Circulating Cardiovascular Markers: Prof. Mark Richards, Director, Cardiovascular Research Institute (CVRI), NUHS Deputy Director, National University Heart Centre, Singapore (NUHCS).
  • Olink Insight: Transform Data to Actionable Information: Dr Sim Wen Jing, Business Development Manager, Olink.

The scientific symposium was held in conjunction with the opening ceremony for the NUS Medicine Protein Biomarker Discovery Core Facility. The core facility will help establish the next-generation proteomics footprint in the South Asian Pacific region, providing the Olink platform to support researchers and scientists in academia and industry, both locally and globally, in their efforts to better understand disease and the effects and outcomes of its treatment. This will  also empower pharmaceutical companies to better understand the mode of action and dose selection of new drugs, and to follow up on their clinical trials.

We would like to express our gratitude to our Guests of Honour: Jenny Egermark, Chargé d’Affaires a.i. at Embassy of Sweden, Singapore; Prof. Chong Yap-Seng, Lien Ying Chow Professor in Medicine, Dean, NUS Yong Loo Lin School of Medicine; and Dr Andrea Ballagi, Asia Pacific VP Sales and Marketing, Olink, for joining us at the event.

We also would like to extend our sincerest thanks to the panelists: Prof. John Chambers, Chief Scientific Offer, NPM program, Professor Cardiovascular Epidemiology, LKC Medicine, NTU; Prof. Mark Richards and Prof. Brian Kennedy.

This was a significant milestone to establish the next-generation proteomics footprint in the South Asia Pacific region,  a ground-breaking action to help technology transfer from disruptive innovation into an implementable platform. It was also successful opportunity to collaborate with this important new external service provider for joint marketing efforts, with a shared, ambitious dream to build up a better global life science ecosystem for the future.